Aptamer-Directed Drug Delivery
First Claim
Patent Images
1. A complex, comprising:
- a nucleic acid targeting moiety; and
a therapeutic agent, wherein the therapeutic agent is capable of associating with the base pairs of the nucleic acid targeting moiety.
8 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides systems, methods, and compositions for targeted delivery of a therapeutic agent organs, tissues, cells, extracellular matrix components, and intracellular compartments. The present invention provides a complex comprising a therapeutic or diagnostic agent and a nucleic acid targeting moiety, wherein the agent non-covalently associates with base pairs of the nucleic acid targeting moiety. The invention provides targeted particles comprising a particle and an inventive complex. The present invention provides methods of designing, manufacturing, and using inventive complexes and targeted particles.
186 Citations
147 Claims
-
1. A complex, comprising:
-
a nucleic acid targeting moiety; and a therapeutic agent, wherein the therapeutic agent is capable of associating with the base pairs of the nucleic acid targeting moiety. - View Dependent Claims (2, 3, 18, 19, 21, 23, 28, 29, 30)
-
-
4-17. -17. (canceled)
-
20. (canceled)
-
22. (canceled)
-
24-27. -27. (canceled)
-
31-44. -44. (canceled)
-
45. A targeted particle, comprising:
-
a particle; and a complex; wherein the complex comprises; a nucleic acid targeting moiety; and a therapeutic agent, wherein the therapeutic agent is capable of intercalating between the base pairs of the nucleic acid targeting moiety. - View Dependent Claims (46, 51, 53, 57, 58, 113)
-
-
47-50. -50. (canceled)
-
52. (canceled)
-
54-56. -56. (canceled)
-
59-112. -112. (canceled)
-
114-143. -143. (canceled)
-
144. A method of preparing a targeted particle comprising:
-
providing a nucleic acid targeting moiety; providing a therapeutic agent, wherein the therapeutic agent is capable of intercalating between the base pairs of the nucleic acid targeting moiety; mixing the nucleic acid targeting moiety with the therapeutic agent to prepare a complex; providing a polymer, wherein the polymer comprises a polyester; producing a particle comprising a polymeric matrix; and associating the particles with the complex; wherein the polymer comprises a polyester, and wherein the nucleic acid targeting moiety targets prostate cancer cells. - View Dependent Claims (145, 146)
-
-
147-148. -148. (canceled)
Specification